The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Naloxone Hydrochloride 400 micrograms/ml Solution for Injection or Infusion



Mercury Pharmaceuticals (Ireland) LtdPA0073/111/002

Main Information

Trade NameNaloxone Hydrochloride 400 micrograms/ml Solution for Injection or Infusion
Active SubstancesNALOXONE HYDROCHLORIDE
Dosage FormSolution for injection/infusion
Licence HolderMercury Pharmaceuticals (Ireland) Ltd
Licence NumberPA0073/111/002

Group Information

ATC CodeV03AB Antidotes
V03AB15 naloxone

Status

License statusAuthorised
Licence Issued03/10/1989
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back